Related Experiment Video
Updated: Aug 9, 2026

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Published on: June 12, 2013
Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro
1Hautklinik, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.
Insights
This study identifies MS-1 high molecular weight protein as a specific marker for cutaneous non-Langerhans cell histiocytoses, aiding in the diagnosis of macrophage disorders. It also characterizes RM 3/1 and 25F9 antigens in various granulomatous and neoplastic conditions.
Area of Science:
- Immunology
- Dermatopathology
Background:
- Macrophages are crucial in immune responses and various diseases, including allergic, granulomatous, and neoplastic conditions.
- Understanding macrophage differentiation is key to diagnosing and managing cutaneous macrophage disorders.
Purpose of the Study:
- To investigate macrophage differentiation pathways in cutaneous disorders and in vitro.
- To identify specific markers for diagnosing histiocytoses and granulomas.
Main Methods:
- Examined 40 cases of cutaneous macrophage disorders using a panel of monoclonal and polyclonal antibodies.
- Analyzed expression of MS-1, RM 3/1, and 25F9 antigens in clinical samples and cultured human monocytes/macrophages.
- Investigated the influence of cytokines (interleukins, interferon-gamma, TNF-alpha) and glucocorticoids on antigen expression.
Main Results:
- MS-1 high molecular weight protein is a specific marker for cutaneous non-Langerhans cell histiocytoses, distinguishing them from Langerhans cell histiocytosis and other granulomas.
- RM 3/1 antigen has a broader expression pattern, including non-Langerhans cell histiocytoses, xanthelasmata, and granulomas.
- 25F9 antigen is strongly expressed in epithelioid cells of sarcoidosis and foreign body granulomas.
- In vitro, RM 3/1 is an early marker, MS-1 is a late marker, and 25F9 is a very late marker of macrophage differentiation.
- Glucocorticoids and IL-4 induce MS-1 and RM 3/1 expression, while IFN-gamma inhibits all three antigens.
Conclusions:
- MS-1 high molecular weight protein is a valuable diagnostic tool for cutaneous non-Langerhans cell histiocytoses.
- RM 3/1 and 25F9 antigens provide further insights into macrophage heterogeneity in various skin conditions.
- Cytokine and glucocorticoid modulation of these markers offers potential therapeutic targets.
Abstract:
Macrophages play important roles in immunity and inflammation, and in allergic, granulomatous and neoplastic diseases. Here, we present the indepth results of an ongoing study of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Up to now, a total of 40 cases of cutaneous macrophage disorders (histiocytoses and granulomas) and related diseases were examined using a panel of monoclonal and polyclonal antibodies to macrophage differentiation antigens (mAb MS-1, mAb alpha CD1a, mAb alpha CD34, mAb RM 3/1, mAb alpha CD11c, mAb alpha CD36, mAb MAC 387, mAb 27E10, polyclonal antibodies alpha MRP-8 and -14, mAb alpha CD68, mAb 25F9, mAb DRC1-R4/23, and mAb 1F10). Of these, MS-1 high molecular weight protein, synthesized by non-continuous sinusoidal endothelial cells and highly dendritic perivascular macrophages in normal human organs, is the most specific macrophage differentiation marker. MS-1 high molecular weight protein is selectively expressed by cutaneous non-Langerhans cell histocytoses, and proves to be a valuable diagnostic tool for these diseases. MS-1 high molecular weight protein is not found in Langerhans cell histiocytosis cells, epithelioid cells in sarcoidosis, and palisading histiocytes in granuloma annulare. MS-1+ macrophages may be found intermingled in cellular type dermatofibroma and in foreign body granulomas; they differ from MS-1+ non-Langerhans cell histiocytosis cells by their highly dendritic morphology, and thus rather resemble the MS-1+ macrophages in normal skin. RM 3/1 antigen shows a similar, but broader expression pattern including non-Langerhans cell histiocytoses, xanthelasmata palpebrarum, foreign body granulomas, granuloma annulare, and cellular type dermatofibroma. Moreover, xanthelasmata palpebrarum paradigmatically represent a class of macrophage lesions with strong RM 3/1, but little MS-1 antigen expression. In sarcoidosis, RM 3/1+ macrophages are only found at the very periphery of epithelioid cell granulomas. In contrast, 25F9 antigen is strongly and consistently expressed in epithelioid cells of sarcoidosis, and in foreign body granulomas. In cultured human monocytes/macrophages, RM 3/1 antigen is expressed early on, while MS-1 high molecular weight protein and 25F9 antigen are late and very late macrophage differentiation antigens, respectively. Expression of RM 3/1 antigen and MS-1 high molecular weight protein is inducible by glucocorticoid and interleukin-4, and less so by interleukin-13 and interleukin-10, and combinations thereof, while 25F9 antigen seems to be less influenced by these agents. Interferon-gamma (and less so tumor necrosis factor-alpha) inhibit expression of all three antigens in cultured human monocytes/macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)

